Greg Everson

2.0k total citations
23 papers, 740 citations indexed

About

Greg Everson is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Greg Everson has authored 23 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 7 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Greg Everson's work include Hepatitis C virus research (9 papers), Liver Disease and Transplantation (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Greg Everson is often cited by papers focused on Hepatitis C virus research (9 papers), Liver Disease and Transplantation (5 papers) and Organ Transplantation Techniques and Outcomes (5 papers). Greg Everson collaborates with scholars based in United States, France and Italy. Greg Everson's co-authors include G Schröter, Mark D. Stegall, Igal Kam, Frederick M. Karrer, Bahri M. Bilir, Chris E. Freise, Robert A. Fisher, Michael Wachs, Anna S. Lok and Thomas H. Sternberg and has published in prestigious journals such as Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

Greg Everson

23 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Everson United States 13 558 361 347 163 70 23 740
Roberto Troisi Belgium 16 373 0.7× 368 1.0× 194 0.6× 161 1.0× 32 0.5× 33 622
Andrea Brunati Italy 15 283 0.5× 378 1.0× 185 0.5× 124 0.8× 51 0.7× 31 536
O. Cuomo Italy 13 395 0.7× 238 0.7× 257 0.7× 57 0.3× 37 0.5× 38 547
T Pillen United States 18 438 0.8× 609 1.7× 217 0.6× 197 1.2× 64 0.9× 41 814
Jeffrey Campsen United States 14 549 1.0× 517 1.4× 286 0.8× 143 0.9× 151 2.2× 51 855
Laura Tariciotti Italy 15 340 0.6× 272 0.8× 266 0.8× 124 0.8× 46 0.7× 35 570
Keiji Kishikawa Japan 16 857 1.5× 708 2.0× 446 1.3× 133 0.8× 34 0.5× 25 1.1k
Taizen Urahashi Japan 15 357 0.6× 477 1.3× 169 0.5× 55 0.3× 100 1.4× 79 679
Robert W. Osorio United States 16 503 0.9× 363 1.0× 356 1.0× 178 1.1× 147 2.1× 30 917
Bettina J. Steffen United States 12 232 0.4× 351 1.0× 191 0.6× 398 2.4× 33 0.5× 12 724

Countries citing papers authored by Greg Everson

Since Specialization
Citations

This map shows the geographic impact of Greg Everson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Everson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Everson more than expected).

Fields of papers citing papers by Greg Everson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Everson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Everson. The network helps show where Greg Everson may publish in the future.

Co-authorship network of co-authors of Greg Everson

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Everson. A scholar is included among the top collaborators of Greg Everson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Everson. Greg Everson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poordad, F., Michael Bennett, Thomas Sepe, et al.. (2016). Ombitasvir/Paritaprevir/R, Dasabuvir, and Sofosbuvir Treatment of Patients with HCV Genotype-Infection who Failed a Prior Course of DAA Therapy: The Quartz-I Study. Journal of Hepatology. 64(2). S767–S768. 18 indexed citations
2.
3.
Afdhal, Nezam H., Greg Everson, José Luís Calleja, et al.. (2014). O68 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF CHRONIC HCV WITH CIRRHOSIS AND PORTAL HYPERTENSION WITH AND WITHOUT DECOMPENSATION: EARLY VIROLOGIC RESPONSE AND SAFETY. Journal of Hepatology. 60(1). S28–S28. 45 indexed citations
4.
Olthoff, Kim M., Jean C. Emond, Tempie H. Shearon, et al.. (2014). Liver regeneration after living donor transplantation: Adult‐to‐adult living donor liver transplantation cohort study. Liver Transplantation. 21(1). 79–88. 72 indexed citations
5.
Terrault, Norah A., Todd R. Stravitz, Anna S. Lok, et al.. (2013). Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study. Hepatology. 59(4). 1311–1319. 12 indexed citations
6.
Ratziu, Vlad, Adrián Gadano, Stanislas Pol, et al.. (2012). 1207 TRIPLE THERAPY WITH DACLATASVIR (DCV; BMS-790052), PEGINTERFERON ALFA-2A AND RIBAVIRIN IN HCV-INFECTED PRIOR NULL AND PARTIAL RESPONDERS: 12-WEEK RESULTS OF PHASE 2B COMMAND-2 TRIAL. Journal of Hepatology. 56. S478–S479. 19 indexed citations
7.
Kulik, Laura, Robert A. Fisher, Robert S. Brown, et al.. (2012). Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort. American Journal of Transplantation. 12(11). 2997–3007. 101 indexed citations
8.
Nelson, David R., Donald M. Jensen, Mark Sulkowski, et al.. (2012). Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy. PubMed. 2012. 1–21. 3 indexed citations
9.
10.
11.
Nelson, Daniel, Paul J. Pockros, Eliot Godofsky, et al.. (2008). 993 HIGH END-OF-TREATMENT RESPONSE (84%) AFTER 4 WEEKS OF R1626, PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN FOLLOWED BY A FURTHER 44 WEEKS OF PEGINTERFERON ALFA-2A AND RIBAVIRIN. Journal of Hepatology. 48. S371–S371. 23 indexed citations
12.
Trotter, James F., Raj J. Shah, Greg Everson, et al.. (2006). Endoscopic Gallbladder Stent Placement for Treatment of Symptomatic Cholelithiasis in Patients with End-Stage Liver Disease. The American Journal of Gastroenterology. 101(2). 278–283. 59 indexed citations
13.
14.
Bak, Thomas H., Michael Wachs, James F. Trotter, et al.. (2000). ADULT DONORS OF RIGHT HEPATIC LOBES FOR LIVINGDONOR LIVER TRANSPLANTATION: RESULTS OF FIRST 16 PATIENTS.. Transplantation. 69(Supplement). S175–S175. 3 indexed citations
15.
Stegall, Mark D., Greg Everson, G Schröter, et al.. (1997). Prednisone Withdrawal Late After Adult Liver Transplantation Reduces Diabetes, Hypertension, and Hypercholesterolemia Without Causing Graft Loss. Hepatology. 25(1). 173–177. 109 indexed citations
16.
Simon, Douglas, S. Gordon, Marshall M. Kaplan, et al.. (1997). Treatment of Chronic Hepatitis C With Interferon Alfa–N3: A Multicenter, Randomized, Open–Label Trial. Hepatology. 25(2). 445–448. 15 indexed citations
17.
Wilner, Keith D., Greg Everson, George Foulds, et al.. (1996). Multiple dose pharmacokinetics of sertraline in subjects with varying degrees of hepatic impairment. European Neuropsychopharmacology. 6. 40–41. 4 indexed citations
18.
Stegall, Mark D., Greg Everson, G Schröter, et al.. (1995). Metabolic complications after liver transplantation. Diabetes, hypercholesterolemia, hypertension, and obesity.. PubMed. 60(9). 1057–60. 135 indexed citations
19.
Shrestha, Roshan, et al.. (1995). Possible idiopathic thrombocytopenic purpura associated with natural alpha interferon therapy for chronic hepatitis C infection.. PubMed. 90(7). 1146–7. 35 indexed citations
20.
Everson, Greg. (1993). Pregnancy and gallstones. Hepatology. 17(1). 159–161. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Troisi Breakdown of academic impact, for papers by Andrea Brunati Breakdown of academic impact, for papers by O. Cuomo Breakdown of academic impact, for papers by T Pillen Breakdown of academic impact, for papers by Jeffrey Campsen Breakdown of academic impact, for papers by Laura Tariciotti Breakdown of academic impact, for papers by Keiji Kishikawa Breakdown of academic impact, for papers by Taizen Urahashi Breakdown of academic impact, for papers by Robert W. Osorio Breakdown of academic impact, for papers by Bettina J. Steffen
Rankless by CCL
2026